It has been proposed elsewhere [Meeker, R. B. & Harden, T. K. (1982) Mol. Pharmacol. 22, [310][311][312][313][314][315][316][317][318][319] that muscarinic cholinergic receptor-mediated attenuation of cAMP accumulation occurs through activation of phosphodiesterase in 1321N1 human astrocytoma cells. Pertussis toxin, which ADP-ribosylates the guanine nucleotide regulatory protein involved in receptor-mediated inhibition of adenylate cyclase (N1), has been utilized to further differentiate between the mechanism of cholinergic regulation of cAMP metabolism in 1321N1 cells and the mechanism involving inhibition of adenylate cyclase in other tissues. Muscarinic receptor-mediated regulation of cAMP accumulation in NG108-15 neuroblastoma-glioma cells occurs through inhibition of adenylate cyclase. Pretreatment of these cells with pertussis toxin completely blocked the capacity of carbachol to attenuate cAMP accumulation. In contrast, concentrations of pertussis toxin two to three orders of magnitude higher than those effective in NG108-15 cells had no effect on muscarinic receptor-mediated attentuation of cAMP accumulation in 1321N1 cells. In addition, no effect of pertussis toxin was observed either on the control rate or the carbachol-stimulated rate of cAMP degradation measured directly in intact 1321N1 cells. A 41,000 Mr protein previously proposed to be the a subunit of N. was labeled during incubation of a plasma membrane fraction from 1321N1 cells with [32P]NAD and pertussis toxin. Pertussis toxin is apparently active in 1321N1 cells, since this protein substrate was not labeled in plasma membrane preparations from cells previously incubated with toxin. Functional activity of N. was demonstrated by the observation that guanosine 5'-[y thioltriphosphate-and GTP-mediated inhibition of forskolinstimulated adenylate cyclase activity occurred in cell-free preparations from 1321N1 cells. The inhibitory activity of these guanine nucleotides was lost in membrane preparations from pertussis toxin-treated cells. The data suggest that adenylate cyclase is not involved in cholinergic action in 1321N1 cells and, furthermore, N. is not involved in muscarinic receptor-mediated activation of phosphodiesterase in these cells. Thus, pertussis toxin can be used to differentiate between two mechanisms of cholinergic regulation of cAMP metabolism.
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Activation of muscarinic cholinergic receptors results in at-
tenuation of cAMP accumulation in intact cells and inhibition of adenylate cyclase activity in cell-free preparations (1) (2) (3) (4) (5) (6) . The GTP dependence of this inhibition (4, 5) , the negative heterotropic effects of guanine nucleotides on agonist binding to inhibitory receptors (6) (7) (8) , and knowledge of the role of the stimulatory guanine nucleotide regulatory protein (N,) in the mechanism of activation of adenylate cyclase (9) have led to the proposal that an inhibitory guanine nucleotide regulatory protein (N,) is involved in the mechanism of receptor-mediated inhibition of adenylate cyclase (10) . Activation and inhibition of adenylate cyclase are differentially sensitive to Mn2+ (10), GTP (10) (11) (12) , and chemical modification by N-ethylmaleimide (6, 13) . Platelets from pseudohypoparathyroid patients are functionally deficient in Ns but express both epinephrine-mediated inhibition of adenylate cyclase and GTP-sensitive high-affinity binding of agonists to a2-adrenergic receptors, suggesting that N1 is fully functional in these cells (14) . Furthermore, cyc-S49 lymphoma cells lack functional Ns but express active N, (15) .
Pertussis toxin, which ADP-ribosylates N1, blocks inhibitory coupling of muscarinic and other receptors to adenylate cyclase (16, 17) . Ns is not a substrate for pertussis toxin (18, 19) . Cholera toxin, which ADP-ribosylates Ns (9) , does not ADP-ribosylate N1 (18, 19) and has no effect on receptormediated inhibition of adenylate cyclase (20) . Thus, muscarinic and other inhibitory receptors regulate adenylate cyclase through a guanine nucleotide regulatory protein that is distinct from the protein involved in regulation of adenylate cyclase by stimulatory receptors; this inhibitory regulatory protein can be identified by its susceptibility to modification by pertussis toxin.
Although muscarinic receptor activation clearly inhibits adenylate cyclase in cell-free preparations from a variety of tissues, analyses of cAMP metabolism in 1321N1 astrocytoma cells (21, 22) , WI-38 fibroblasts (23, 24) , and thyroid slices (25) have led to the conclusion that muscarinic receptor stimulation also results in activation of phosphodiesterase. We have proposed that this is the sole mechanism by which cAMP levels are reduced in 1321N1 astrocytoma cells, since, in the presence of phosphodiesterase inhibitors, cholinergic agonist-mediated decreases in cAMP levels do not occur, and muscarinic receptor-mediated inhibition of adenylate cyclase is not detected in membrane preparations from these cells (21) .
One explanation for the mechanism of regulation of cAMP metabolism in 1321N1 cells is that muscarinic receptors are coupled through N1 to activation of phosphodiesterase rather than inhibition of adenylate cyclase. The occurrence of guanine nucleotide-mediated activation of phosphodiesterase in several tissues supports this possibility. For example, a wellcharacterized GTP regulatory protein, transducin, couples the light-activated receptor (rhodopsin) of the retinal rod outer segment to activation of a cGMP phosphodiesterase (26) . On the basis of amino acid composition and electrophoretic patterns of the proteolyzed polypeptides, transducin, Ns, and N, appear to be structurally similar guanine nucleotide regulatory proteins (27) [32P]ADP-ribosylation. Preparation of plasma membrane fractions was as previously described (42) . ADP-ribosylation was carried out at 30'C for 90 min in a final volume of 0.5 ml containing pertussis toxin (10 Ag of protein), gradient-purified membranes (120 pug of protein), 10 AM [a-32PJNAD (1) (2) Ci/ mmol), 1 mM thymidine, 0.5 mM ATP, 5 mM dithiothreitol, 2.5 mM MgCl2, 6 mM potassium phosphoenolpyruvate, pyruvate kinase at 10,tg/ml, and 100 mM Tris, pH 8.0. The reaction was stopped by the addition of 1 ml of ice-cold 50 mM Tris, pH 7.4, and centrifugation at 10,000 x g for 5 min.
The labeled membranes were washed three times by resuspension in ice-cold 50 mM Tris, pH 7.4, and centrifugation, incubated overnight in 100 Al of Laemmli sample buffer (43) , and then applied to a 12.5% sodium dodecyl sulfate discontinuous polyacrylamide gel with a 4% stacking gel. Gels were fixed; stained with Coomassie brilliant blue, and dried, and autoradiograms were developed, using Kodak XAR-15 film.
Adenylate Cyclase Assay. Adenylate cyclase activity was quantitated as previously described (6) . 
RESULTS
The activity of pertussis toxin was examined in a cell line (NG108-15 neuroblastoma-glioma cells) that expresses a well-characterized muscarinic receptor-linked adenylate cyclase system. Concentration-effect curves for CARB-mediated inhibition of cAMP accumulation were generated in NG108-15 cells pretreated overnight with pertussis toxin or vehicle (Fig. 1) . CARB (100,uM) inhibited PGE,-stimulated cAMP accumulation by 65% in control cells. Pretreatment with pertussis toxin enhanced PGE1-stimulated cAMP accumulation. At the high concentration of pertussis toxin, CARB failed to attenuate PGE1-stimulated cAMP accumulation. In addition, the capacity of epinephrine and morphine to inhibit cAMP accumulation through a2-adrenergic and opiate receptors, respectively, was blocked by pretreatment with pertussis toxin (data not shown). These results are consistent with those previously reported by Kurose et al. (17 (Fig. 2) .
Since muscarinic receptor activation enhances cAMP degradation in 1321N1 cells (21, 22) , the effect of pertussis toxin on the kinetics of cAMP degradation was examined directly.
cAMP synthesis was stimulated with 10 AM ISO for 10 min.
Propranolol then was added to the cells to block further cAMP synthesis and the decrease in cAMP levels, which is a function of phosphodiesterase activity, was measured in the absence or presence of CARB over the following 3 min. As we have previously shown (21, 22) , the disappearance of cAMP was a first-order process (Fig. 3) . The The presence of a 41,000 Mr substrate for pertussis toxin in 1321N1 cells does not necessarily prove the presence of functional N.. Indeed, the lack of muscarinic receptor-mediated inhibition of adenylate cyclase in spite of the presence of muscarinic receptors and adenylate cyclase could be explained by the absence of N, or its presence in a functionally altered form. Seamon and Daly (46) have presented data supporting the idea that inhibition of forskolin-stimulated adenylate cyclase activity by guanine nucleotides provides a measure of the functional activity of N;. That is, since forskolin "maximally" activates adenylate cyclase, the stimulatory effects of guanine nucleotides are not observed in the presence of forskolin, and, thus, the inhibitory effects of these nucleotides mediated through N; become apparent. As illustrated in Fig. 5 , both GTP and GTP[yS] inhibited forskolin-stimulated adenylate cyclase activity in 1321N1 membranes. The values for the half-maximal effect for each of the nucleotides were similar to those observed in membranes from other tissues (15, 36) . In contrast to cohtrol membranes, neither guanine nucleotide inhibited (in fact, a stimulation was observed) adenylate cyclase in membranes from pertussis toxin-pretreated cells. In addition to blockade of the inhibitory effects of guanine nucleotides, pertussis toxin pretreatment resulted in a decrease in forskolin-stimulated activity measured in the absence of a guanine nucleotide.
DISCUSSION
Earlier work by this laboratory (21, 22) led to the proposal that activation of muscarinic cholinergic receptors in 1321N1 cells reduces cAMP levels by activating phosphodiesterase: (i) the time necessary to attain maximal cAMP levels is reduced in the presence of a muscarinic receptor agonist; (it) inhibitors of phosphodiesterase noncompetitively block the inhibitory effect of muscarinic receptors on cAMP accumulation; (iii) muscarinic receptor agonists increase the rate of cAMP degradation assessed directly in intact cells; ( (26, 31) , to the less well-understood recent findings suggesting regulation of liverphosphodiesterase by GTP (28, 29) . It recently has been reported that pertussis toxin ADP-ribosylates and modifies the function of transducin (31, 32) and that pertussis toxin blocks the insulin-induced activation ofparticulate phosphodiesterase activity in 3T3 adipocytes (33 
